Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Immunology of Bladder Cancer - Pilot Studies
Taylor, Graham
(Principal Investigator)
Immunology and Immunotherapy
Overview
Fingerprint
Research output
(1)
Project Details
Short title
Immunology of Bladder Cancer - Pilot Studies
Status
Finished
Effective start/end date
1/01/12
→
31/03/14
Funding
Cancer Research UK
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
interleukin-17
Agriculture & Biology
100%
urinary bladder neoplasms
Agriculture & Biology
92%
Parkinson disease
Agriculture & Biology
72%
mast cells
Agriculture & Biology
71%
Mycobacterium bovis
Medicine & Life Sciences
65%
Interleukin-17
Medicine & Life Sciences
64%
Mast Cells
Medicine & Life Sciences
59%
Urinary Bladder Neoplasms
Medicine & Life Sciences
58%
Research output
Research output per year
2017
2017
2017
1
Article
Research output per year
Research output per year
Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer
Dowell, A.
,
Cobby, E.
,
Wen, K.
,
Devall, A.
,
During, V.
,
Anderson, J.
,
James, N.
,
Cheng, K.
,
Zeegers, M.
,
Bryan, R.
&
Taylor, G.
,
20 Sept 2017
,
In:
PLoS ONE.
12
,
9
, e0184841.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
interleukin-17
100%
urinary bladder neoplasms
92%
Parkinson disease
72%
mast cells
71%
Mycobacterium bovis
65%
10
Citations (Scopus)
163
Downloads (Pure)